Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HPTN 081 AMP Study
PACTR202005582198497Phase 2Unknown
- Sponsor
- NIAID Division of AIDS
- Start
- Dec 2016
- Modality
- Anti-infectious Disease mAbs → Neutralizing Antibodies → Monoclonal Antibodies → Antibody-Based Therapeutics, Naked Antibodies → Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of VRC01 and Placebo-COD Research Private Ltd in human immunodeficiency virus infection (HIV) (3 arms), sponsored by NIAID Division of AIDS. Status: unknown.
02
Drugs
VRC01Placebo-COD Research Private Ltd
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on PACTR202005582198497.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202005582198497.